Research Topics |
Detail Information
Publications
Gabapentin. PfizerGlen Wheeler
Curr Opin Investig Drugs 3:470-7. 2002..In September 2001, Morgan Stanley predicted sales of US $1871 million in 2002 falling to US $413 million in 2006...
RG-1068 RepliGenGlen Wheeler
Curr Opin Investig Drugs 4:66-71. 2003..RG-1068 received Fast Track designation for the treatment of pediatric autism in September 2001, and in February 2002, it entered phase III clinical trials...
Ruboxistaurin (Eli Lilly)Glen D Wheeler
102 711 West 17th Avenue, Vancouver, BC V5Z 1V1, Canada
IDrugs 6:159-63. 2003....
